Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4294983 | 0.80 | TSHR (0.36) | TSHRTDP1 | |
| SCHEMBL4618318 | 0.79 | — | — | |
| SCHEMBL1341716 | 0.78 | — | — | |
| SCHEMBL27403877 | 0.74 | TSHR (0.30) | TSHRTDP1 | |
| SCHEMBL28018986 | 0.74 | — | — | |
| SCHEMBL306915 | 0.74 | — | — | |
| SCHEMBL3030245 | 0.71 | — | — | |
| SCHEMBL27976951 | 0.71 | TSHR (0.35) | TSHR | |
| SCHEMBL28018092 | 0.71 | TSHR (0.35) | TSHR | |
| SCHEMBL27976617 | 0.71 | TSHR (0.35) | TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 31 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20150368380-A1 | ANTIMICROBIAL POLYMER | Fachhochschule Münster (DE) | 2015-12-24 | — | — | US | claimed |
| US-10138307-B2 | Antimicrobial polymer | Fachhochschule Münster (DE) | 2018-11-27 | — | — | US | disclosed |
| CN-104955926-B | For improving the lubricant compositions for including epoxide compound of fluoropolymer sealant compatibility | 巴斯夫欧洲公司 | 2018-06-22 | — | — | CN | disclosed |
| CN-105247025-B | Seal compatibility additives for lubricant compositions for improving fluoropolymer seal compatibility | 巴斯夫欧洲公司 | 2017-12-01 | — | — | CN | disclosed |
| CN-107109278-A | For the sulphonic acid ester for the fluoropolymer seal part compatibility for improving lubricant compositions | 巴斯夫欧洲公司 | 2017-08-29 | — | — | CN | disclosed |
| CN-104822810-B | Comprising boroxin and amines to improve the lubricant compositions of fluoropolymer seal part compatibility | 巴斯夫欧洲公司 | 2017-03-08 | — | — | CN | disclosed |
| EP-2976087-A1 | ROR GAMMA MODULATORS | ETH Zürich (CH) | 2016-01-27 | — | — | EP | disclosed |
| CN-105283529-A | Seal compatibility additives for lubricant compositions for improving fluoropolymer seal compatibility | BASF SE | 2016-01-27 | — | — | CN | disclosed |
| CN-105247025-A | Seal compatibility additives for lubricant compositions for improving fluoropolymer seal compatibility | BASF SE | 2016-01-13 | — | — | CN | disclosed |
| CN-105247024-A | Seal compatibility additives for lubricant compositions for improving fluoropolymer seal compatibility | BASF SE | 2016-01-13 | — | — | CN | disclosed |
| US-7842706-B2 | Pharmaceutical composition | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2010-11-30 | — | — | US | disclosed |
| US-20090246232-A1 | Pharmaceutical composition | TAKEDA PHARMACEUTICAL COMPANY, LIMITED | 2009-10-01 | — | — | US | disclosed |
| CN-101522813-A | Resin composition and molded article obtained from the composition | MITSUI CHEMICALS INC (JP) | 2009-09-02 | — | — | CN | disclosed |
| US-7538125-B2 | Pharmaceutical composition | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2009-05-26 | — | — | US | disclosed |
| US-20070203198-A1 | Pharmaceutical composition | TAKEDA PHARMACEUTICAL COMPANY LIMITED | 2007-08-30 | — | — | US | disclosed |
| US-7144900-B2 | Insulin sensitivity enhancer such as 5 -[[4-[2-(methyl-2-pyridylamino)ethoxy]phenyl]methyl]-2,4-thiazolidinedione or salt and a statin; antidiabetic agent | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2006-12-05 | — | — | US | disclosed |
| US-20050054685-A1 | Pharmaceutical composition | TAKEDA CHEMICAL INDUSTRIES, LTD. | 2005-03-10 | — | — | US | disclosed |
| EP-0779281-B1 | ISOXAZOLES | SANKYO CO (JP) | 2003-10-29 | — | — | EP | disclosed |
| US-5965591-A | MONOAMINE OXIDASE INHIBITOR; FOR PROPHYLAXIS AND TREATING PARKINSON'S DISEASE, DEPRESSION AND ALZHEIMER'S DISEASE | SANKYO COMPANY, LIMITED (JP) | 1999-10-12 | — | — | US | disclosed |
| EP-0779281-A1 | ISOXAZOLES | SANKYO COMPANY LIMITED (JP) | 1997-06-18 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10138307-B2 | Antimicrobial polymer | PUF60, PARG, DPM1 | TSHR 4853/4885TDP1 3198/4885 |
| US-20050054685-A1 | Pharmaceutical composition | GPR119, IAPP, INSR | TSHR 1868/4885TDP1 2516/4885 |
| US-20070203198-A1 | Pharmaceutical composition | GPR119, IAPP, INSR | TSHR 1868/4885TDP1 2516/4885 |
| US-20090246232-A1 | Pharmaceutical composition | GPR119, IAPP, INSR | TSHR 1868/4885TDP1 2516/4885 |
| US-20150368380-A1 | ANTIMICROBIAL POLYMER | PUF60, PARG, DPM1 | TSHR 4853/4885TDP1 3198/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.